Dr. Omid Farokhzad

Dr. Omid Farokhzad is an Iranian-American physician-scientist, entrepreneur, and a leading pioneer in the field of nanomedicine and targeted drug delivery. He is renowned for his groundbreaking work in engineering smart nanoparticles for the diagnosis and treatment of diseases, particularly cancer. His research has successfully translated from the laboratory to clinical applications, leading to the founding of several successful biotechnology companies. Farokhzad holds prestigious appointments at Harvard Medical School and Brigham and Women's Hospital and is an elected member of the National Academy of Medicine.

Early life and education

Born in Tehran, Iran, Farokhzad developed an early interest in science and medicine. He immigrated to the United States for his higher education, where he pursued a combined M.D. and M.A. program. He earned his medical degree from Boston University School of Medicine and completed a master's degree in organic chemistry at Boston University. Following this, he undertook his clinical training in internal medicine and fellowship in nephrology at Brigham and Women's Hospital, a major teaching affiliate of Harvard Medical School. His postdoctoral research fellowship was conducted at the Massachusetts Institute of Technology under the mentorship of renowned professor Robert Langer, which solidified his focus on biomaterials and drug delivery systems.

Career and research

Dr. Farokhzad's career is distinguished by his dual role as a translational researcher and a serial entrepreneur. He is a Professor at Harvard Medical School and the Director of the Center for Nanomedicine at Brigham and Women's Hospital. His seminal research involves the development of biocompatible and biodegradable polymeric nanoparticles that can be precisely engineered to target specific cells, such as cancer cells, while sparing healthy tissue. This work on targeted therapeutics has led to multiple Investigational New Drug applications and human clinical trials. A cornerstone of his career is the co-founding of several biopharmaceutical companies, including BIND Therapeutics, which advanced Accurin nanoparticles, Selecta Biosciences, focused on Synthetic Vaccine Particles, and more recently, Seer Biosciences and Karat Bioscience, leveraging proteomics and immunology for disease detection and treatment.

Awards and honors

Farokhzad's contributions have been recognized with numerous prestigious awards. He is a recipient of the Lemelson–MIT Prize, often described as the "Oscar for Inventors." He has been honored with the Ellison Medical Foundation Senior Scholar Award and the John H. Dresher Award. His election to the National Academy of Medicine is considered one of the highest honors in the fields of health and medicine. He has also been named a Fellow of the American Institute for Medical and Biological Engineering and the National Academy of Inventors, and his work was featured on the Popular Science "Best of What's New" list.

Selected publications

Farokhzad has authored over 150 peer-reviewed scientific papers and is an inventor on more than 200 issued and pending patents worldwide. His highly cited publications appear in leading journals such as Nature Nanotechnology, Proceedings of the National Academy of Sciences, and Cancer Research. Key publications often focus on the rational design of nanoparticle-aptamer bioconjugates, the clinical translation of nanomedicine platforms, and the application of combinatorial chemistry methods for developing targeted drug delivery systems. His work is frequently presented at major conferences including those of the American Association for Cancer Research and the Controlled Release Society.

Personal life

Dr. Farokhzad maintains a private personal life. He is married and has children. He is known to be an advocate for STEM education and frequently mentors young scientists and entrepreneurs. In interviews, he has cited his immigrant experience and the interdisciplinary environment at MIT and Harvard as formative influences on his approach to solving complex problems in translational medicine.

Category:American nanotechnologists Category:Harvard Medical School faculty Category:National Academy of Medicine members Category:American people of Iranian descent Category:Living people